We tested whether prophylactic droperidol and ondansetron, in combination with a moderate dose of dexamethasone, were equally effective in reducing nausea and vomiting after tonsillectomy in children and that both were superior to saline with dexamethasone. We randomly allocated 300 children to intravenous saline, droperidol 10 lg.kg . The rates (95%CI) of nausea or vomiting within 24 postoperative hours were: 42/91 after saline, 46% (36%-57%); 43/87 after droperidol, 49% (39%-60%); reduced to 18/84 by ondansetron, 21% (13%-32%), p < 0.001. There were no differences in the rates of side-effects between groups. We conclude that ondansetron is more effective than saline in preventing nausea or vomiting after paediatric tonsillectomy when given with a moderate dose of dexamethasone, whereas droperidol was not.
Introduction
Tonsillectomy, with or without adenoidectomy, is a common paediatric operation. Nearly 50% of children are nauseated or vomit postoperatively without antiemetic prophylaxis [1] [2] [3] . Postoperative nausea and vomiting are associated with bleeding, aspiration of gastric contents, electrolyte disturbances, dehydration, prolonged length of stay and hospital re-admission [4] [5] [6] .
Dexamethasone prophylaxis reduces postoperative nausea and vomiting in children [7] , despite which nausea and vomiting occur in 24%-44% of children [2, 8] . The addition of 5-hydroxytryptamine receptor (5-HT 3 ) antagonists augments anti-emesis with high doses of dexamethasone [9, 10] . High doses of dexamethasone have been associated with bleeding after tonsillectomy [2] . It is unclear to what extent ondansetron might reduce nausea and vomiting when given with moderate doses of dexamethasone. The addition of droperidol to dexamethasone further reduces nausea and vomiting in adults, but the combination has not been investigated in children [11] .
This randomised, double-blind trial tested the hypothesis that droperidol and ondansetron, in combination with a moderate dose of dexamethasone, were equally effective in reducing nausea and vomiting after tonsillectomy in children and that both were superior to dexamethasone alone.
Methods
The Lausanne University Hospital Ethics Board approved this prospectively registered trial that we reported following standard guidelines [12] . We recruited children scheduled for bilateral tonsillectomy, with or without adenoidectomy, who were aged 2-10 years, ASA physical status 1-2 and weighed at least 15 kg. Parents provided written informed consent. We did not study children who had had study drugs within 24 h or in whom they were contra-indicated.
We used 10 computer-generated randomly permuted blocks of 30 numbers containing 10 allocations to each of three study groups. The allocation sequence was stored and protected by the pharmacy department: the code could be broken in case of a possible serious adverse reaction. Participants, clinical personnel and outcome assessors were unaware of group allocation. The pharmacy prepared sequentially numbered syringes, formulated so that the correct dose of study drug in ml.kg -1 could be injected intravenously into children: saline; droperidol 10 lg.kg
À1
; and ondansetron 150 lg.kg À1 [7, 13, 14] .
Before surgery, we gave children oral atropine 0.04 mg.kg À1 and methadone 150 lg.kg
. We induced anaesthesia with sevoflurane in oxygen and nitrous oxide, completed after gaining peripheral intravenous access with propofol 3-4 mg. The primary outcome was the rate of postoperative nausea or vomiting within the first 24 postoperative hours, after telephoning parents at home. Secondary outcomes included: the rates of vomiting, nausea or vomiting and rescue antie-mesis in the recovery ward; the rates of vomiting and nausea or vomiting after discharge; and rates of hospitalisation and re-admission. We also recorded rates of headache, extrapyramidal syndrome or drowsiness and dose of intravenous morphine administered in the recovery ward. Surgeons recorded the rates of tonsillar haemorrhage one week and two months after surgery.
We calculated that 98 children in each of the droperidol and ondansetron groups would have 80% power to demonstrate equivalence within 15% at a statistical threshold of 0.05, assuming a rate of postoperative nausea or vomiting of 40% in a saline group of 98 children (based on unpublished pilot data) [15] . These numbers also had 90% power to detect superiority of both experimental treatments compared with saline at a statistical threshold of 0.025 (Bonferroni correction). We planned to enrol 100 children in each of three groups.
We used Student's t-test or ANOVA to compare means. We used Pearson's chi-squared test or Fisher's exact test to compare rates, and the Clopper-Pearson exact method to calculate their confidence intervals. We considered p < 0.05 significant. We corrected pairwise post-hoc analyses to a statistical threshold of 0.017. We used a generalised linear regression model with a log link and binomial family distribution to assess treatment effect independent of sex, age, weight, duration of surgery and anaesthesia, type of operation and dose of postoperative intravenous morphine [16, 17] . We used JMP 9 (SAS Institute, Cary, NC, USA) and Stata (v. 14.1, StataCorp, College Station, TX, USA) for analyses.
Results
We recruited 300 children and analysed data from 262 ( Fig. 1 and Table 1 ). The rates (95%CI) of nausea and vomiting within 24 postoperative hours were: 42/91 after saline, 46% (36%-57%); 43/87 after droperidol, 49% (39%-60%); and reduced to 18/84 after ondansetron, 21% (13%-32%), p < 0.001. The rates (95%CI) of vomiting within 24 postoperative hours were: 33/91 after saline, 36% (26%-47%); 35/87 after droperidol, 40% (30%-51%); and reduced to 12/84 after ondansetron, 14% (8%-24%), p = 0.002. Adjustment for covariates did not change the p values. Table 2 lists the rates of outcomes in hospital.
The rates (95%CI) of headache were: 5/91 after saline, 6% (2%-12%); 8/87 after droperidol, 9% (4%-17%); and 2/84 after ondansetron, 2% (0%-8%), p = 0.16. One child exhibited extrapyramidal symptoms after saline and one after ondansetron, and two children exhibited symptoms after droperidol, p = 0.77. No child was drowsy after saline, whereas one child was drowsy after droperidol and one was drowsy after ondansetron, p = 0.39.
One child after droperidol and one after ondansetron returned to theatre for haemostasis before discharge. Ten days after surgery, one child exhibited mild bleeding from the tonsillar bed after droperidol and three did after ondansetron, p = 0.12. Data were unavailable for bleeding in eight children who did not attend clinic (three after saline and five after droperidol). Twelve children, four in each group, remained in hospital overnight because of pain or social reasons. Five children were re-admitted due to nausea or vomiting, one after saline and two each after droperidol and ondansetron, p = 0.78.
Discussion
We showed that in children given dexamethasone, prophylactic ondansetron reduced the rate of nausea or vomiting after tonsillectomy, with or without adenoidectomy, whereas droperidol did not.
Droperidol has been previously shown to reduce postoperative nausea or vomiting in children, but with
doses eight-times more than recommended [7] , at the expense of increased extrapyramidal symptoms [18] .
The rate of haemorrhage in our trial was lower than previously reported [2, 19] , despite our routine use of dexamethasone and non-steroidal anti-inflammatory drugs. Recent evidence suggests that dexamethasone does not increase bleeding after tonsillectomy [19, 20] . The seniority and expertise of the surgeons in our study, combined with the standardisation of the surgical procedure and its short duration, may have contributed to the low rate of haemorrhage [9, 21] .
Our study has several limitations. Dexamethasone may have antagonised the independent anti-emetic effects of droperidol and ondansetron and we do not know what the rates of nausea and vomiting were in our cohort beyond 24 postoperative hours.
In conclusion, the combination of dexamethasone with ondansetron was more effective than dexamethasone alone for the prophylaxis of nausea and vomiting after paediatric tonsillectomy. We did not detect an additive antie-metic effect with droperidol. 
